Übersicht
The staff within the Gene Transfer, Targeting and Therapeutics Viral Vector Core provide expert consultation for the safe and effective use of viral vector technologies, and offer custom design and production services for multiple viral vector types. The Gene Transfer, Targeting and Therapeutics Viral Vector Core facilitates the use of these powerful research tools by Salk researchers and others across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, aging, cancer biology and gene therapy.
The U.S. Bureau of Industry and Security has updated the Export Administration Regulations regarding rabies vectors. We are now able to distribute reagents that contain any portion of the rabies genome only to countries that are part of the Australia Group:
https://www.dfat.gov.au/publications/minisite/theaustraliagroupnet/site/en/participants.html
National Cancer Institute
The GT3 core is a designated Cancer Center Council (C3) core facility. Cancer Center members from participating C3 institutes receive shared resource rates.
Für die Einreichung von Manuskripten, die Dienste oder Ressourcen dieser Core-Einheit genutzt haben, bitten wir Sie, die Unterstützung anzuerkennen, indem Sie die folgenden Informationen aufnehmen:
“This work was supported by the GT3 Core Facility of the Salk Institute with funding from NIH-NCI CCSG: P30 CA014195”. Please acknowledge core staff where appropriate and consider authorship inclusion when scientific contributions merit.
Bitte verknüpfen Sie jede aus der Arbeit im Kern resultierende Veröffentlichung mit Ihrem MyNCBI-Konto. Dies stellt sicher, dass die Beiträge von NIH in Verlängerungs- und Fortsetzungsanträgen angemessen anerkannt werden. Diese NIH-Anforderung muss als Teil unserer Bemühungen erfüllt werden, einen konsistenten Zugang zu stabilen finanzierten Kernressourcen zu ermöglichen. Informationen zur Verknüpfung von Publikationen finden Sie hier»
10010 N Torrey Pines Rd
La Jolla, CA 92037
Telefon: (858) 453-4100
Our offices are located just North of the Salk Institute in the Sanford Consortium for Regenerative Medicine building.
Office Location
Room 1318
Lab Location
Room 1106
GT3 Core email: GT3@salk.edu
John Naughton
Director, Gene Transfer, Targeting and Therapeutics Viral Vector Core
(858) 453-4100 ext. 1891
jnaughton@salk.edu
